Professional Documents
Culture Documents
Pre-test
Name: ______________________________________ Date:___________________
1. Osteoporosis is characterized by :
a. ___________________________
b. ___________________________
c. ___________________________
a. ___________________________
b. ___________________________
c. ___________________________
d. ___________________________
e. ___________________________
a. ___________________________________
b. ___________________________________
c. ___________________________________
a. ___________________________
b. ___________________________
c. ___________________________
8. Most common type of Osteoporotic fracture is ___________________________________________.
_________________________________________________________________________________.
a. ___________________________
b. ___________________________
c. ___________________________
a. ___________________________
b. ___________________________
c. ___________________________
a. ___________________________
b. ___________________________
c. ___________________________
a. ___________________________
b. ___________________________
c. ___________________________
d. ___________________________
e. ___________________________
17. Gold standard for Osteoporosis diagnosis is _____________________________________________.
_________________________________________________________________________________.
a.
b.
c.
23. ______% of women and ________% of men 50+ years of age will suffer Osteoporotic fracture.
_________________________________________________________________________________.
26. Fracture Reduction in women with Osteoporosis (reported by FIT Trial) was :
a. Vertebral ___________________________
b. Hip ___________________________
c. Wrist___________________________
27. Mean cumulative increase in BMD by Alendronate (reported by FLEX Trial) was :
b. Trochanter___________________________
28. Fracture Reduction in women with vertebral fracture (reported by FIT Trial) was :
a. Vertebral _______________
___________________________
b. Hip ___________________________
c. Wrist___________________________
a. At Spine ___________________________
b. At Trochanter ___________________________
c. At Femoral Neck___________________________
30. Mean increase in BMD by Alendronate in men with Osteoporosis (reported by Orwell 2000) was :
b. Trochanter___________________________
c. Femoral Neck___________________________